EicOsis is developing a first-in-class therapy of a once daily, oral treatment for neuropathic and inflammatory pain in humans and companion animals. EicOsis is developing inhibitors to a the soluble epoxide hydrolase, a key regulatory enzyme involved in the metabolism of fatty acids, to treat unmet medical needs in human and animals. sEH inhibitors treat pain by stabilizing natural analgesic and anti-inflammatory mediat...
EicOsis is developing a first-in-class therapy of a once daily, oral treatment for neuropathic and inflammatory pain in humans and companion animals. EicOsis is developing inhibitors to a the soluble epoxide hydrolase, a key regulatory enzyme involved in the metabolism of fatty acids, to treat unmet medical needs in human and animals. sEH inhibitors treat pain by stabilizing natural analgesic and anti-inflammatory mediators.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.